3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
12
Non-Muscle Invasive Bladder Neoplasms
9
Carcinoma, Transitional Cell
7
Stomach Neoplasms
4
Anus Neoplasms
4
Pancreatic Neoplasms
3
Carcinoma, Hepatocellular
3
Peritoneal Neoplasms
2
Liver Neoplasms
2
Colorectal Neoplasms
2
Appendiceal Neoplasms
2
Urologic Neoplasms
1
Urologic Diseases
1
Urogenital Neoplasms
1
Urinary Bladder Diseases
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Pseudomyxoma Peritonei
1
Neoplasms by Site
1
Neoplasms
1
Neoplasm Recurrence, Local
1
Neoplasm Metastasis
1
Mycobacterium Infections
1
Gastrointestinal Neoplasms
1
Dermatitis
1
Carcinoma in Situ
1
Carcinoma
1
Anal Canal Carcinoma
1
Adenocarcinoma
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Mitomycin
×
Clear all
No trials found.